Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
Crohn’s disease
risk perception
screening
ulcerative colitis
Journal
Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
received:
06
07
2021
pubmed:
7
9
2021
medline:
6
7
2022
entrez:
6
9
2021
Statut:
ppublish
Résumé
Patients with inflammatory bowel disease (IBD) undergo surveillance colonoscopies at fixed intervals to reduce the risk of colorectal cancer (CRC). Taking patients' preferences for determining surveillance strategies into account could improve adherence and patient satisfaction. This study aimed to determine patient preferences for CRC surveillance in IBD. We conducted a web-based, multicenter, discrete choice experiment among adult IBD patients with an indication for surveillance. Individuals were repeatedly asked to choose between 3 hypothetical surveillance scenarios. The choice tasks were based on bowel preparation (0.3-4 L), CRC risk reduction (8% to 1%-6%), and interval (1-10 years). Attribute importance scores, trade-offs, and willingness to participate were calculated using a multinomial logit model. Latent class analysis was used to identify subgroups with similar preferences. In total, 310 of 386 sent out questionnaires were completed and included in the study. Bowel preparation was prioritized (attribute importance score 40.5%) over surveillance interval and CRC risk reduction (31.1% and 28.4%, respectively). Maximal CRC risk reduction, low-volume bowel preparation (0.3 L laxative with 2 L clear liquid) with 2-year surveillance was the most preferred combination. Three subgroups were identified: a "surveillance avoidant," "CRC risk avoidant," and "surveillance preferring" groups. Membership was correlated with age, educational level, perceived CRC risk, the burden of bowel preparation, and colonoscopies. Inflammatory bowel disease patients consider bowel preparation as the most important element in acceptance of CRC surveillance. Heterogeneity in preferences was explained by 3 latent subgroups. These findings may help to develop an individualized endoscopic surveillance strategy in IBD patients. This discrete choice experiment identified volume of bowel preparation as the attribute impacting patients’ preferences regarding colitis-associated colorectal cancer surveillance most. Three subgroups were identified with similar preferences and distinct clinical characteristics.
Sections du résumé
BACKGROUND
Patients with inflammatory bowel disease (IBD) undergo surveillance colonoscopies at fixed intervals to reduce the risk of colorectal cancer (CRC). Taking patients' preferences for determining surveillance strategies into account could improve adherence and patient satisfaction. This study aimed to determine patient preferences for CRC surveillance in IBD.
METHODS
We conducted a web-based, multicenter, discrete choice experiment among adult IBD patients with an indication for surveillance. Individuals were repeatedly asked to choose between 3 hypothetical surveillance scenarios. The choice tasks were based on bowel preparation (0.3-4 L), CRC risk reduction (8% to 1%-6%), and interval (1-10 years). Attribute importance scores, trade-offs, and willingness to participate were calculated using a multinomial logit model. Latent class analysis was used to identify subgroups with similar preferences.
RESULTS
In total, 310 of 386 sent out questionnaires were completed and included in the study. Bowel preparation was prioritized (attribute importance score 40.5%) over surveillance interval and CRC risk reduction (31.1% and 28.4%, respectively). Maximal CRC risk reduction, low-volume bowel preparation (0.3 L laxative with 2 L clear liquid) with 2-year surveillance was the most preferred combination. Three subgroups were identified: a "surveillance avoidant," "CRC risk avoidant," and "surveillance preferring" groups. Membership was correlated with age, educational level, perceived CRC risk, the burden of bowel preparation, and colonoscopies.
CONCLUSIONS
Inflammatory bowel disease patients consider bowel preparation as the most important element in acceptance of CRC surveillance. Heterogeneity in preferences was explained by 3 latent subgroups. These findings may help to develop an individualized endoscopic surveillance strategy in IBD patients.
This discrete choice experiment identified volume of bowel preparation as the attribute impacting patients’ preferences regarding colitis-associated colorectal cancer surveillance most. Three subgroups were identified with similar preferences and distinct clinical characteristics.
Autres résumés
Type: plain-language-summary
(eng)
This discrete choice experiment identified volume of bowel preparation as the attribute impacting patients’ preferences regarding colitis-associated colorectal cancer surveillance most. Three subgroups were identified with similar preferences and distinct clinical characteristics.
Identifiants
pubmed: 34487155
pii: 6364945
doi: 10.1093/ibd/izab221
pmc: PMC9247845
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1053-1060Informations de copyright
© 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation.
Références
BMC Health Serv Res. 2020 May 26;20(1):467
pubmed: 32456702
Gastroenterology. 2010 Feb;138(2):738-45
pubmed: 20141808
Clin Gastroenterol Hepatol. 2012 Nov;10(11):1225-31
pubmed: 22940741
Clin Gastroenterol Hepatol. 2015 Sep;13(9):1656-61
pubmed: 25956835
Eur J Cancer. 2010 Jan;46(1):150-9
pubmed: 19683432
Patient. 2017 Oct;10(5):553-565
pubmed: 28364387
J Crohns Colitis. 2019 Feb 1;13(2):144-164
pubmed: 30137275
Clin Gastroenterol Hepatol. 2012 Jun;10(6):639-45
pubmed: 22289873
PLoS One. 2020 Jan 16;15(1):e0227635
pubmed: 31945089
Value Health. 2016 Mar-Apr;19(2):202-9
pubmed: 27021754
Value Health. 2016 Jun;19(4):300-15
pubmed: 27325321
J Psychosom Res. 2018 Nov;114:58-61
pubmed: 30314580
Clin Gastroenterol Hepatol. 2020 Feb;18(2):406-414.e7
pubmed: 31100456
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):789-99
pubmed: 23448792
Patient Prefer Adherence. 2017 May 18;11:947-958
pubmed: 28572722
Expert Rev Gastroenterol Hepatol. 2021 Feb;15(2):211-216
pubmed: 32981385
Value Health. 2011 Jun;14(4):403-13
pubmed: 21669364
Patient. 2021 Mar;14(2):269-281
pubmed: 33150461
J Behav Med. 2020 Feb;43(1):121-130
pubmed: 31065890
Scand J Gastroenterol. 2016 Nov;51(11):1326-31
pubmed: 27311071
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1454-1465.e14
pubmed: 31683057
Gastroenterology. 2006 Apr;130(4):1030-8
pubmed: 16618396
Patient. 2015 Oct;8(5):373-84
pubmed: 25726010
J Gastrointest Surg. 2019 Jul;23(7):1309-1317
pubmed: 30478530
Health Econ. 2002 Jul;11(5):457-65
pubmed: 12112494
Gastroenterology. 2018 Aug;155(2):252-257
pubmed: 29964039
Value Health. 2011 Dec;14(8):1101-8
pubmed: 22152180
Inflamm Bowel Dis. 2013 Mar;19(3):534-9
pubmed: 23429444
Gut. 2012 Mar;61(3):459-65
pubmed: 22187072
Value Health. 2018 Jul;21(7):767-771
pubmed: 30005748
Gastroenterol Res Pract. 2012;2012:483417
pubmed: 22190913
Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):531-542
pubmed: 29058478
Am J Gastroenterol. 2018 Dec;113(12):1801-1809
pubmed: 30353058